PAPER Noriega L, Díaz A, Limón D, Castro ME, Caballero NA, Ramírez RE, Perez-Aguilar JM, Melendez FJ

Inhibitory mechanism of 17β-aminoestrogens in the formation of Aβ aggregates.

J Mol Model. 2019 Jul 18;25(8):229. PubMed: 31321557

PAPER Hillary RF, McCartney DL, Harris SE, Stevenson AJ, Seeboth A, Zhang Q, Liewald DC, Evans KL, Ritchie CW, Tucker-Drob EM, Wray NR, McRae AF, Visscher PM, Deary IJ, Marioni RE

Genome and epigenome wide studies of neurological protein biomarkers in the Lothian Birth Cohort 1936.

Nat Commun. 2019 Jul 18;10(1):3160. PubMed: 31320639

PAPER Liesz A

The vascular side of Alzheimer's disease.

Science. 2019 Jul 19;365(6450):223-224. PubMed: 31320524

PAPER Qiu Y, Jacobs DM, Messer K, Salmon DP, Feldman HH

Cognitive heterogeneity in probable Alzheimer disease: Clinical and neuropathologic features.

Neurology. 2019 Jul 18; PubMed: 31320469

PAPER Passamonti L, Tsvetanov KA, Jones PS, Bevan-Jones WR, Arnold R, Borchert RJ, Mak E, Su L, O'Brien JT, Rowe JB

Neuroinflammation and functional connectivity in Alzheimer's disease: interactive influences on cognitive performance.

J Neurosci. 2019 Jul 18; PubMed: 31320450

PAPER Díaz-Montaña JJ, Díaz-Díaz N, Barranco CD, Ponzoni I

Development and use of a Cytoscape app for GRNCOP2.

Comput Methods Programs Biomed. 2019 Aug;177:211-218. Epub 2019 Jun 4 PubMed: 31319950

PAPER Potter H, Chial HJ

Targeting the Interaction Between Apolipoprotein E and Amyloid Precursor Protein: A Novel Alzheimer's Disease Therapy.

Biol Psychiatry. 2019 Aug 1;86(3):169-170. PubMed: 31319935

PAPER Mizuta K, Saneyoshi T

Amyloid-β-Dependent Neuronal Circuit Rearrangement in Presymptomatic Alzheimer's Disease.

Biol Psychiatry. 2019 Aug 1;86(3):167-168. PubMed: 31319934

PAPER Sadleir KR, Vassar R

RPS23RG1 May Prevent Ubiquitin-Proteosomal Degradation of Postsynaptic Densities-93 and-95 to Protect Synaptic Function: Implications for Alzheimer's Disease.

Biol Psychiatry. 2019 Aug 1;86(3):164-166. PubMed: 31319933

PAPER Park YW, Shin NY, Chung SJ, Kim J, Lim SM, Lee PH, Lee SK, Ahn KJ

Magnetic Resonance Imaging-Visible Perivascular Spaces in Basal Ganglia Predict Cognitive Decline in Parkinson's Disease.

Mov Disord. 2019 Jul 19; PubMed: 31322758

PAPER Kramer AO, Casaletto KB, Umlauf A, Staffaroni AM, Fox E, You M, Kramer JH

Robust normative standards for the California Verbal Learning Test (CVLT) ages 60-89: A tool for early detection of memory impairment.

Clin Neuropsychol. 2019 Jul 19;:1-22. PubMed: 31322042

PAPER Hergert DC, Haaland KY, Cimino CR

Evaluation of a performance-rating method to assess awareness of cognitive functioning in Huntington's disease.

Clin Neuropsychol. 2019 Jul 19;:1-21. PubMed: 31322031

PAPER Leroi I, Vatter S, Carter LA, Smith SJ, Orgeta V, Poliakoff E, Silverdale MA, Raw J, Ahearn DJ, Taylor C, Rodda J, Abdel-Ghany T, McCormick SA

Parkinson's-adapted cognitive stimulation therapy: a pilot randomized controlled clinical trial.

Ther Adv Neurol Disord. 2019;12:1756286419852217. Epub 2019 Jul 4 PubMed: 31320931

PAPER Yoon JA, Kong IJ, Choi J, Baek JY, Kim EJ, Shin YI, Ko MH, Shin YB, Shin MJ

Neural Compensatory Response During Complex Cognitive Function Tasks in Mild Cognitive Impairment: A Near-Infrared Spectroscopy Study.

Neural Plast. 2019;2019:7845104. Epub 2019 Jun 19 PubMed: 31320893

PAPER Yoon EJ, Ismail Z, Hanganu A, Kibreab M, Hammer T, Cheetham J, Kathol I, Sarna JR, Martino D, Furtado S, Monchi O

Mild behavioral impairment is linked to worse cognition and brain atrophy in Parkinson disease.

Neurology. 2019 Jul 18; PubMed: 31320470